Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-23-000019

Chief Operations Officer acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Johnston Lloyd P. · Chief Operations Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-01-02 Grant or award : show line 1 in the form +100,000 275,299 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-01-02 Grant or award : show line 2 in the form Employee Stock Option (right to buy) +475,000 475,000 D
Loading xslF345X03/wf-form4_167286967765220.xml…